CALYPTE BIOMEDICAL CORP Research and Development Expense
CALYPTE BIOMEDICAL CORP reported Research and Development Expense of $259.00 thousand for the 12-month period ending 2012-12-31, per its 10-K filed 2014-06-24.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2014-06-24
- CALYPTE BIOMEDICAL CORP research and development expense for the quarter ending 2012-12-31 was $55.00K, a 21.43% decline year-over-year.
- CALYPTE BIOMEDICAL CORP research and development expense for the quarter ending 2012-09-30 was $62.00K, a 27.06% decline year-over-year.
- CALYPTE BIOMEDICAL CORP research and development expense for the quarter ending 2012-06-30 was $68.00K, a 1.49% increase year-over-year.
- CALYPTE BIOMEDICAL CORP research and development expense for the quarter ending 2012-03-31 was $74.00K, a 0.00% change year-over-year.
- CALYPTE BIOMEDICAL CORP research and development expense for fiscal 2012 was $259.00K, a 12.50% decline from fiscal 2011.
- CALYPTE BIOMEDICAL CORP research and development expense for fiscal 2011 was $296.00K, a 4.96% increase from fiscal 2010.
- CALYPTE BIOMEDICAL CORP research and development expense for fiscal 2010 was $282.00K.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2012-12-31 | $55.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-24 | $117.00K derived: sum of 2 quarters · filed 2014-06-24 | $185.00K derived: sum of 3 quarters · filed 2014-06-24 | $259.00K 10-K · filed 2014-06-24 |
| 2012-09-30 | $62.00K 10-Q · filed 2012-12-31 | $130.00K derived: sum of 2 quarters · filed 2012-12-31 | $204.00K 10-Q · filed 2012-12-31 | $274.00K derived: sum of 4 quarters · filed 2014-06-24 |
| 2012-06-30 | $68.00K 10-Q · filed 2012-08-14 | $142.00K 10-Q · filed 2012-08-14 | $212.00K derived: sum of 3 quarters · filed 2014-06-24 | $297.00K derived: sum of 4 quarters · filed 2014-06-24 |
| 2012-03-31 | $74.00K 10-Q · filed 2012-05-15 | $144.00K derived: sum of 2 quarters · filed 2014-06-24 | $229.00K derived: sum of 3 quarters · filed 2014-06-24 | $296.00K derived: sum of 4 quarters · filed 2014-06-24 |
| 2011-12-31 | $70.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-24 | $155.00K derived: sum of 2 quarters · filed 2014-06-24 | $222.00K derived: sum of 3 quarters · filed 2014-06-24 | $296.00K 10-K · filed 2014-06-24 |
| 2011-09-30 | $85.00K 10-Q · filed 2012-12-31 | $152.00K derived: sum of 2 quarters · filed 2012-12-31 | $226.00K 10-Q · filed 2012-12-31 | $319.00K derived: sum of 4 quarters · filed 2012-12-31 |
| 2011-06-30 | $67.00K 10-Q · filed 2012-08-14 | $141.00K 10-Q · filed 2012-08-14 | $234.00K derived: sum of 3 quarters · filed 2012-08-14 | $303.00K derived: sum of 4 quarters · filed 2012-08-14 |
| 2011-03-31 | $74.00K 10-Q · filed 2012-05-15 | $167.00K derived: sum of 2 quarters · filed 2012-05-15 | $236.00K derived: sum of 3 quarters · filed 2012-05-15 | $272.00K derived: sum of 4 quarters · filed 2012-05-15 |
| 2010-12-31 | $93.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-22 | $162.00K derived: sum of 2 quarters · filed 2012-03-22 | $198.00K derived: sum of 3 quarters · filed 2012-03-22 | $282.00K 10-K · filed 2012-03-22 |
| 2010-09-30 | $69.00K 10-Q · filed 2012-01-27 | $105.00K derived: sum of 2 quarters · filed 2012-01-27 | $189.00K 10-Q · filed 2012-01-27 | |
| 2010-06-30 | $36.00K 10-Q/A · filed 2011-11-30 | $120.00K 10-Q/A · filed 2011-11-30 |